Spinal Tech

Surgical Frontiers closed on a $7 million fund for the company's future growth.

Medtronic gained Food and Drug Administration clearance for the SHILLA Growth Guidance System for patients with severe early-onset spinal deformities.

Spine Pain Management added Peter Dalrymple to the board of directors.

A report from BCC research estimates growth in the surgical navigation systems market through 2018.

Exactech Director Albert H. Burstein sold 8,852 shares of the company's stock on Monday, Aug. 25, according to an InterCooler report.

The St. Louis Post-Dispatch reported two Republican lawmakers are profiting from Medtronic's acquisition of Covidien and subsequent headquarters move from Minnesota to Ireland in a tax inversion strategy.

LDR CEO Christophe Lavigne sold 25,000 shares of the company's stock on the open market yesterday.

Orthopedic and spine device companies are hot in healthcare investment today, and many investors are looking for the next best opportunities.

Cesca Therapeutics presented findings from a case study highlighting the potential clinical benefit and cost savings of its SurgWerks-CLI cell therapy to CMS.

  Medtronic acquired Sapiens Steering Brain Stimulation for around $200 million in an all-cash transaction.